Amiodarone Pulmonary Toxicity
Authors:
Open Access
- 1 January 2009
- journal article
- conference paper
- Published by Wiley in Canadian Respiratory Journal
- Vol. 16 (2) , 43-48
Abstract
Amiodarone is an antiarrhythmic agent commonly used to treat supraventricular and ventricular arrhythmias. This drug is an iodine‐containing compound that tends to accumulate in several organs, including the lungs. It has been associated with a variety of adverse events. Of these events, the most serious is amiodarone pulmonary toxicity. Although the incidence of this complication has decreased with the use of lower doses of amiodarone, it can occur with any dose. Because amiodarone is widely used, all clinicians should be vigilant of this possibility. Pulmonary toxicity usually manifests as an acute or subacute pneumonitis, typically with diffuse infiltrates on chest x‐ray and high‐resolution computed tomography. Other, more localized, forms of pulmonary toxicity may occur, including pleural disease, migratory infiltrates, and single or multiple nodules. With early detection, the prognosis is good. Most patients diagnosed promptly respond well to the withdrawal of amiodarone and the administration of corticosteroids, which are usually given for four to 12 months. It is important that physicians be familiar with amiodarone treatment guidelines and follow published recommendations for the monitoring of pulmonary as well as extrapulmonary adverse effects.Keywords
Funding Information
- Mount Sinai Hospital Center – Montreal
This publication has 38 references indexed in Scilit:
- Amiodarone‐induced pulmonary toxicityBritish Journal of Clinical Pharmacology, 2008
- Amiodarone toxicity presenting as pulmonary mass and peripheral neuropathy: the continuing diagnostic challenge2006
- Detection of Amiodarone-Induced Pulmonary Toxicity in Supine and Prone Positions-High-Resolution Computed Tomography Study-Circulation Journal, 2005
- Amiodarone pulmonary toxicityClinics in Chest Medicine, 2004
- Case 12-2003New England Journal of Medicine, 2003
- Attenuation of Amiodarone-Induced Pulmonary Fibrosis by Vitamin E Is Associated with Suppression of Transforming Growth Factor-β1 Gene Expression but Not Prevention of Mitochondrial DysfunctionThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Is Amiodarone an Underrecognized Cause of Acute Respiratory Failure in the ICU?Chest, 2001
- Amiodarone Toxicity in A Patient with Simultaneous Involvement of Cornea, Thyroid Gland, and LungThe American Journal of the Medical Sciences, 2000
- Amiodarone to Prevent Recurrence of Atrial FibrillationNew England Journal of Medicine, 2000
- Amiodarone pulmonary toxicity. Clinical, radiologic, and pathologic correlationsArchives of internal medicine (1960), 1987